Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | ||
| Net Income | -18,403 | N/A |
| Depreciation Amortization | 1,063 | N/A |
| Accounts receivable | -508 | N/A |
| Accounts payable and accrued liabilities | -1,058 | N/A |
| Other Working Capital | -3,074 | N/A |
| Other Operating Activity | 3,119 | 0 |
| Operating Cash Flow | $-18,861 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,860 | N/A |
| Investing Cash Flow | $-1,860 | $N/A |
| Cash Flows From Financing Activities | ||
| Debt Repayment | 5 | N/A |
| Common Stock Issued | 27,600 | N/A |
| Other Financing Activity | -4,991 | 0 |
| Financing Cash Flow | $22,614 | $N/A |
| Exchange Rate Effect | -47 | N/A |
| Beginning Cash Position | 16,483 | N/A |
| End Cash Position | 18,329 | N/A |
| Net Cash Flow | $1,846 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -18,861 | N/A |
| Capital Expenditure | -1,860 | N/A |
| Free Cash Flow | -20,721 | 0 |